Form 4: Intuitive Surgical SVP Wadors Sells Shares After RSU Vesting
Insider Transaction Report
Intuitive Surgical's SVP of Human Resources, Patricia Wadors, sold common stock following the vesting of restricted stock units, executed under a pre-arranged 10b5-1 trading plan.
Summary
- Patricia L. Wadors, SVP Chief Human Resources Officer at Intuitive Surgical Inc. (ISRG), acquired 458 shares of common stock on February 26, 2026, through the vesting of Restricted Stock Units (RSUs).
- On the same date, 238 shares of common stock were disposed of at a price of $506.17 per share to cover statutory tax withholding requirements related to the RSU vesting.
- On February 27, 2026, Wadors sold 220 shares of common stock at a price of $499.71 per share.
- These transactions were conducted in accordance with a Rule 10b5-1 trading plan, which is set to expire on June 5, 2026.
- Following these reported transactions, Wadors directly beneficially owns 0 shares of common stock.
- Additionally, Wadors disposed of 458 Restricted Stock Units (RSUs) that vested on February 26, 2026, and acquired 3,584 new Restricted Stock Units on the same date.
- RSUs typically vest 25% per year over a four-year period, commencing on the first anniversary of the grant date, and convert into common stock on a one-for-one basis upon vesting.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, representing routine executive compensation and personal financial management under a pre-arranged plan, with no immediate positive or negative implications for the company's operational performance or outlook.
Positives
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned and not reactive sale, which is a standard practice for insiders.
- The acquisition of 3,584 new Restricted Stock Units demonstrates continued equity compensation and aligns the executive's interests with the company's long-term performance.
Negatives
- The sale of 220 shares of common stock by a senior executive, while routine, represents a reduction in direct equity exposure, though it is a relatively small number of shares.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that executive stock sales, particularly those executed under Rule 10b5-1 plans, are common occurrences in the technology and medical device sectors. These transactions allow executives to manage personal finances and diversify holdings while adhering to insider trading regulations, and typically do not signal a change in company fundamentals.
Related Party Transactions
- The reported transactions involve an executive officer of Intuitive Surgical Inc. selling company stock, which constitutes a related party transaction.
Stakeholder Impact
- Shareholders: The sale of a relatively small number of shares by a senior executive is unlikely to have a significant impact on the overall share price or shareholder sentiment, especially given it was pre-planned.
- Employees: No direct impact on employees is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 02/26/2025 | Implied grant date for a tranche of Restricted Stock Units, with the first anniversary vesting on 02/26/2026. |
| 02/26/2026 | Date of RSU vesting, acquisition of common stock, disposition of shares for tax withholding, and acquisition of new Restricted Stock Units. |
| 02/27/2026 | Date of common stock sale. |
| 06/05/2026 | Expiration date of the Rule 10b5-1 Trading Plan. |
Recommendation
holdThe filing details routine insider transactions (RSU vesting, tax withholding, and a small sale) executed under a 10b5-1 plan. These are not indicative of a change in company fundamentals or a strong signal for future stock performance, thus a 'hold' recommendation is appropriate as it doesn't provide new information to alter an existing investment thesis.
Keywords
Intuitive Surgical, ISRG, Patricia Wadors, Form 4, insider trading, stock sale, RSU vesting, 10b5-1 plan, executive compensation, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.